Arena Pharmaceuticals, Inc. Deferred Tax Liabilities, Net
Arena Pharmaceuticals, Inc. had Deferred Tax Liabilities, Net of $5.90 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2022-02-23
- 2021-12-31: Deferred Tax Liabilities, Net $5.90M.
- 2020-12-31: Deferred Tax Liabilities, Net $4.56M.
- 2019-12-31: Deferred Tax Liabilities, Net $2.22M.
- 2012-12-31: Deferred Tax Liabilities, Net $0.00.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2021-12-31 | $5.90M 10-K · filed 2022-02-23 |
| 2020-12-31 | $4.56M 10-K · filed 2022-02-23 |
| 2019-12-31 | $2.22M 10-K · filed 2021-02-23 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-01 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-01 |